Visualising the uncertainty of toxidromic classification in an era of increasing multisubstance use. Co-detections are common and most individual clinical signs point to multiple substance classes simultaneously. The associations are derived from the ASSIST study; analysing toxicological detections and symptoms from 1,348 presentations to the Queen Elizabeth University Hospital, Glasgow from 2022-2025.